Počet záznamů: 1
Mitochondrial targeting of [alpha]-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy
SYS 0360075 LBL 04041^^^^^2200673^^^450 005 20240103195232.7 014 $a 000290603700010 $2 WOS 017 70
$a 10.1016/j.freeradbiomed.2011.02.032 $2 DOI 100 $a 20120312d m y slo 03 ba 101 0-
$a eng $d eng 102 $a US 200 1-
$a Mitochondrial targeting of [alpha]-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy 215 $a 10 s. 463 -1
$1 001 cav_un_epca*0256631 $1 011 $a 0891-5849 $e 1873-4596 $1 200 1 $a Free Radical Biology and Medicine $v Roč. 50, č. 11 (2011), s. 1546-1555 $1 210 $c Elsevier 610 0-
$a Triphenyl phosphonium 610 0-
$a reactive oxygen species 610 0-
$a apoptosis 700 -1
$3 cav_un_auth*0243250 $a Dong $b L.-F. $y AU $4 070 701 -1
$3 cav_un_auth*0278015 $a Jameson $b V.J.A. $y NZ $4 070 701 -1
$3 cav_un_auth*0277401 $a Tilly $b D. $y AU $4 070 701 -1
$3 cav_un_auth*0015245 $a Procházka $b L. $y CZ $4 070 701 -1
$3 cav_un_auth*0250927 $a Rohlena $b Jakub $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0239912 $a Vališ $b Karel $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0271606 $a Truksa $b Jaroslav $i Laboratoř nádorové rezistence $j Laboratory of Tumour Resistance $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0243053 $a Zobalová $b Renata $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0279097 $a Mandavian $b E. $y US $4 070 701 -1
$3 cav_un_auth*0277400 $a Klučková $b Katarína $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0226880 $a Stantic $b M. $y AU $4 070 701 -1
$3 cav_un_auth*0258703 $a Štursa $b Jan $i 970/97 $j Scientific-Service Teams: Bioorganic Chemistry of Saccharides, Glycoconjugates, and Delivery Systems for Target Therapy $k 970/97 $l 970/97 $p UOCHB-X $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0236318 $a Freeman $b R. $y AU $4 070 701 -1
$3 cav_un_auth*0278017 $a Witting $b P.K. $y AU $4 070 701 -1
$3 cav_un_auth*0279098 $a Norberg $b E. $y SE $4 070 701 -1
$3 cav_un_auth*0250930 $a Goodwin $b J. $y AU $4 070 701 -1
$3 cav_un_auth*0052075 $a Salvatore $b B.A. $y US $4 070 701 -1
$3 cav_un_auth*0279099 $a Novotná $b Jana $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $4 070 $T Biotechnologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0015239 $a Turánek $b J. $y CZ $4 070 701 -1
$3 cav_un_auth*0103588 $a Ledvina $b Miroslav $i 970/97 $j Scientific-Service Teams: Bioorganic Chemistry of Saccharides, Glycoconjugates, and Delivery Systems for Target Therapy $k 970/97 $l 970/97 $p UOCHB-X $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0051818 $a Hozák $b Pavel $i Oddělení biologie buněčného jádra $j Laboratory of Biology of the Cell Nucleus $k 25 $l 25 $p UMG-J $w Laboratory of Biology of the Cell Nucleus $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0279101 $a Zhivotovsky $b B. $y SE $4 070 701 -1
$3 cav_un_auth*0278019 $a Coster $b M. $y AU $4 070 701 -1
$3 cav_un_auth*0226812 $a Ralph $b S.J. $y AU $4 070 701 -1
$3 cav_un_auth*0279102 $a Smith $b R.A.J. $y NZ $4 070 701 -1
$3 cav_un_auth*0239896 $a Neužil $b Jiří $i Laboratoř molekulární terapie $j Laboratory of Molecular Therapy $p BTO-N $w Development of Diagnostic and Therapeutic Procedures $z G $4 070 $T Biotechnologický ústav AV ČR, v. v. i.
Počet záznamů: 1